Cargando…
Biosimilars: Beginning a Conversation
Autores principales: | Campen, Christopher J., Mayden, Kelley D., McBride, Ali, Swit, Michael |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Harborside Press
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5679036/ https://www.ncbi.nlm.nih.gov/pubmed/29152384 |
Ejemplares similares
-
Practical Strategies for Advanced Practitioners Streamlining the Integration of Oncology Biosimilar Therapies Into Practice
por: Mayden, Kelley D., et al.
Publicado: (2022) -
Getting Familiar With Biosimilars
por: Mayden, Kelley D.
Publicado: (2016) -
Biosimilars in the United States: Considerations for Oncology Advanced Practitioners
por: Mayden, Kelley D., et al.
Publicado: (2015) -
Integrating Biosimilars Into Oncology Practice: Implications for the Advanced Practitioner
por: Campen, Christopher J.
Publicado: (2017) -
A Review of the Totality of Evidence Supporting the Development of the First Adalimumab Biosimilar ABP 501
por: Markus, Richard, et al.
Publicado: (2019)